Catalyst Financial Partners LLC Dexcom Inc Transaction History
Catalyst Financial Partners LLC
- $455 Billion
- Q2 2024
A detailed history of Catalyst Financial Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Catalyst Financial Partners LLC holds 2,244 shares of DXCM stock, worth $155,935. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,244
Previous 2,155
4.13%
Holding current value
$155,935
Previous $288 Million
11.8%
% of portfolio
0.06%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,111Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.23 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.4 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.13 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.06 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$830 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.8B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...